Vimedimex Medi-Pharma JSC (HOSE:VMD)

Vietnam · Delayed Price · Currency is VND

13,800

-200 (-1.43%)

At close: Jul 24, 2026

Vimedimex Medi-Pharma JSC Financials Overview

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Revenue	812,983	812,983	1,249,868	3,536,651	7,073,499	12,318,752
Revenue Growth	-30.69%	-34.96%	-64.66%	-50.00%	-42.58%	-32.17%
Gross Profit	82,316	82,316	118,944	279,256	544,766	1,068,687
Operating Income	42,716	42,716	5,497	35,019	32,149	152,733
Net Income	42,361	42,361	22,016	25,482	34,818	19,995
Earnings Per Share	2743.54	2743.54	1425.89	1650.00	2255.00	1295.00
EPS Growth	44.52%	92.41%	-13.58%	-26.83%	74.13%	-46.10%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Cash & Investments	353,542	353,542	335,082	249,455	256,375	179,911
Total Debt	-	-	-	-	-	612,374
Net Cash (Debt)	353,542	353,542	335,082	249,455	256,375	-432,463
Net Cash Growth	-3.73%	5.51%	34.33%	-2.70%	-	-
Net Cash Per Share	22897.43	22897.43	21701.83	16152.32	16604.34	-28008.76

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Operating Cash Flow	10,565	10,565	118,674	21,872	702,082	-422,016
Capital Expenditures	-	-	-7,001	-16,329	-5,163	-20,468
Free Cash Flow	10,565	10,565	111,673	5,543	696,919	-442,484
Free Cash Flow Growth	-94.97%	-90.54%	1914.81%	-99.20%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Gross Margin	10.13%	10.13%	9.52%	7.90%	7.70%	8.67%
Operating Margin	5.25%	5.25%	0.44%	0.99%	0.45%	1.24%
Pretax Margin	6.61%	6.61%	2.45%	1.13%	0.67%	0.23%
Profit Margin	5.21%	5.21%	1.76%	0.72%	0.49%	0.16%
FCF Margin	1.30%	1.30%	8.94%	0.16%	9.85%	-3.59%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 25, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
PE Ratio	5.03	6.01	11.57	10.30	9.27	27.41
P/FCF Ratio	-	24.12	2.28	47.36	0.46	-
PS Ratio	0.26	0.31	0.20	0.07	0.05	0.04